Comprehensive analysis of cardiac arrhythmias in telemetered cynomolgus monkeys over a 6month period

Journal of Pharmacological and Toxicological Methods

Volumn 66, Issue 2, 2012, Pages 84-91

  Chui, Ray W ^a   Derakhchan, Katayoun ^a   Vargas, Hugo M ^a  

^a AMGEN INC   (United States)

Author keywords

Arrhythmia; Circadian; Cynomolgus; ECG; Monkey; Telemetry

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR BLOCK; CIRCADIAN RHYTHM; COMPUTER PROGRAM; ELECTROCARDIOGRAM; HAPLORHINI; HEART ARRHYTHMIA; INCIDENCE; MALE; NONHUMAN; PATTERN RECOGNITION; PREVALENCE; SAFETY; SINUS NODE; SUPRAVENTRICULAR PREMATURE BEAT; TELEMETRY; WAVEFORM;

ANIMALS; ANIMALS, LABORATORY; ARRHYTHMIAS, CARDIAC; CARDIAC COMPLEXES, PREMATURE; CIRCADIAN RHYTHM; ELECTROENCEPHALOGRAPHY; HEART BLOCK; MACACA FASCICULARIS; MALE; MODELS, ANIMAL; REFERENCE VALUES; SINOATRIAL NODE; TELEMETRY; TIME FACTORS;

ANIMALIA; MACACA FASCICULARIS;

EID: 84865617667     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2012.05.002     Document Type: Article

References (31)

1. Ando K., Hombo T., Kanno A., Ikeda H., Imaizumi M., Shimizu N., et al. QT PRODACT: In vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation. Journal of Pharmacological Sciences 2005, 99:487-500.
2. Bazett H.C. An analysis of the time-relations of electrocardiograms. Heart 1920, 7. 353-370.
3. Blasi E., Bamberger M., Knight D., Engwall M., Wolk R., Winter S., et al. Effects of CP-532,623 and torcetrapib, cholesteryl ester transfer protein inhibitors, on arterial blood pressure. Journal of Cardiovascular Pharmacology 2009, 53:507-516.
4. Chapman K., Pullen N., Coney L., Dempster M., Andrews L., Bajramovic J., et al. Preclinical development of monoclonal antibodies: Considerations for the use of non-human primates. MAbs 2009, 1:505-516.
5. Chui R.W., Fosdick A., Conner R., Jiang J., Bruenner B.A., Vargas H.M. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants. Journal of Pharmacological and Toxicological Methods 2009, 60:58-68.
6. Chui R.W., Vargas H.M. A comparison of three software platforms for automated ECG analysis. Journal of Pharmacological and Toxicological Methods 2009, 60:28-38.
7. Cools F., Gallacher D.J. Normal prevalence of cardiac arrhythmias in 24h ECG recordings of chronically telemetered, healthy, freely moving beagle dogs. Journal of Pharmacological and Toxicological Methods 2009, 60:235-236. (Abstract).
8. Cools F., Janssens S., Vanlommel A., Teisman A., Towart R., Gallacher D.J. ECG arrhythmias in non-implanted vs. telemetry-implanted dogs: Need for screening before and sufficient recovery time after implantation. Journal of Pharmacological and Toxicological Methods 2011, 64:60-67.
9. Derakhchan K., Chui R.W., Vargas H.M. Evaluation of cardiac conduction disturbances using jacketed external telemetry (JET) in conscious non-human primates (NHP). Journal of Pharmacological and Toxicological Methods 2011, 64:e46.
10. Duerr F.M., Carr A.P., Duke T., Shmon C.L., Monnet E. Prevalence of perioperative arrhythmias in 50 young, healthy dogs. Canadian Veterinary Journal 2007, 48:169-177.
11. Gauvin D.V., Tilley L.P., Smith F.W., Baird T.J. Electrocardiogram, hemodynamics, and core body temperatures of the normal freely moving cynomolgus monkey by remote telemetry. Journal of Pharmacological and Toxicological Methods 2006, 53:140-151.
12. Gauvin D.V., Tilley L.P., Smith F.W.K., Baird T.J. Spontaneous arrhythmias recorded in three experimentally- and drug-naïve laboratory species (canine, primate, swine) during standard pre-study screening. Journal of Pharmacological and Toxicological Methods 2009, 59:57-61.
13. Hamlin R.L. Non-drug-related electrocardiographic features in animal models in safety pharmacology. Journal of Pharmacological and Toxicological Methods 2005, 52:60-76.
14. Haushalter T.M., Friedrichs G.S., Reynolds D.L., Barecki-Roach M., Pastino G., Hayes R., et al. The cardiovascular and pharmacokinetic profile of dofetilide in conscious telemetered beagle dogs and cynomolgus monkeys. British Journal of Pharmacology 2008, 154:1457-1464.
15. Hayes E., Pugsley M.K., Penz W.P., Adaikan G., Walker M.J.A. Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates. Journal of Pharmacological and Toxicological Methods 1994, 32:201-207.
16. Henriques T.A., Beck T.W., Douglas C.L., Jones H.M., Kremer J.J., Kruzich P.J., et al. Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high-quality electrocardiogram signals. Journal of Pharmacological and Toxicological Methods 2010, 62:136-142.
17. ICH E14 Expert working group (efficacy) of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Clinical evaluation of QT/QTc interval prolongation and proarrhythmia potential for non-antiarrhythmic drugs 2005.
18. ICH S7B International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals 2005.
19. Jeyaraj D., Haldar S.M., Wan X., McCauley M.D., Ripperger J.A., Hu K., et al. Circadian rhythms govern cardiac repolarization and arrhythmogenesis. Nature 2012, 483:96-99.
20. Kremer J.J., Foley C.M., Xiang Z., Lemke E., Sarazan R.D., Osinski M.A., et al. Comparison of ECG signals and arrhythmia detection using jacketed external telemetry and implanted telemetry in monkeys. Journal of Pharmacological and Toxicological Methods 2011, 64:e47.
21. Leishman D.J., Beck T.W., Dybdal N., Gallacher D.J., Guth B.D., Holbrook M., Roche B., Wallis R.M. Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: Current recommendations from the Safety Pharmacology Society. Journal of Pharmacological and Toxicological Methods 2012, 65:93-101.
22. Macallum G.E., Houston B.J. Characterization of cardiac alterations in nonsedated cynomolgus monkeys. American Journal of Veterinary Research 1993, 54:327-332.
23. Min S.S., Turner J.R., Nada A., DiMino T.L., Hynie I., Kleiman R., et al. Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development. American Heart Journal 2010, 159:716-729.
24. Pugsley M.K., Authier S., Curtis M.J. Principles of safety pharmacology. British Journal of Pharmacology 2008, 154:1382-1399.
25. Sasaki H., Shimizu N., Suganami H., Yamamoto K. QT PRODACT: Inter-facility variability in electrocardiographic and hemodynamic parameters in conscious dogs and monkeys. Journal of Pharmacological Science 2005, 99:513-522.
26. Shen Y.T. Primate models for cardiovascular drug research and development. Current Opinion in Investigational Drugs 2010, 11:1025-1029.
27. Soloviev M.V., Hamlin R.L., Barrett R.M., Chengelis C.P., Schaefer G.J. Different species require different correction factors for the QT interval. Cardiovascular Toxicology 2006, 6:145-157.
28. Sugiyama A. Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodeled hearts. British Journal of Pharmacology 2008, 154:1528-1537.
29. Ulloa H.M., Houston B.J., Altrogge D.M. Arrhythmia prevalence during ambulatory electrocardiographic monitoring of beagles. American Journal of Veterinary Research 1995, 56:275-281.
30. Vidal J.D., Drobatz L.S., Holliday D.F., Geiger L.E., Thomas H.C. Spontaneous findings in the heart of Mauritian-origin cynomolgus macaques (Macaca fascicularis). Toxicologic Pathology 2010, 38:297-302.
31. Walker M.J.A., Curtis M.J., Hearse D.J., Campbell R.W.F., Janse M.J., Yellon D.M., et al. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovascular Research 1988, 22:447-455.